经尿道等离子体双极电切术治疗前列腺增生

Transurethral plasmakinetic resection of prostate for treatment of benign prostatic hyperplasia

目的：探讨经尿道等离子体双极电切术（plasmakinetic resection of prostate,PKRP）治疗良性前列腺增生（BPH）的安全性和疗效。方法：回顾性分析2006年2月-2007年3月经尿道等离子体双极电切治疗BPH98例临床资料。前列腺重量30-140 g。结果：PKRP手术时间30-180 min。切除前列腺组织重量22-102 g。无经尿道电切综合征发生。术后随访2-12个月,最大尿流率由术前平均6.2 ml/s升到术后18.9 ml/s。国际前列腺症状评分由术前平均26.1分降到术后7.3分。结论：经尿道等离子体双极电切术治疗BPH具有安全性高、并发症少、疗效好的优点。

Objective：To evaluate the safety and efficacy of transurethral plasmakinetic resection of prostate （PKRP）. Methods：The data of benign prostatic hyperplasia（BPH） patients with PKRP from February 2006 to March 2007 were reviewed. The weight of the prostate was between 30 g and 140 g. Results：The operation lasted for 30 to 180 rain. The resected tissues weighed 22 - 102 g. During the operation, no transurethral prostatic resection syndrome occurred. All patients were followed up for 2 - 12 months. Average maximum flow-rate increasedfrom 6.2 ml/s preoperatively to 18.9 m/s postoperatively. International prostatic symptom score（IPSS） decreased from average 26. 1 preoperatively to average 7.3 postoperatively. Conclusions ：PKRP is effective with high safety and less complications.